|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| (11) | Number of the document | 3423105 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17711475.8 |
| Date of filing the European patent application | 2017-03-02 | |
| (97) | Date of publication of the European application | 2019-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation | 2021-09-10 |
| (86) | Number | PCT/US2017/020529 |
| Date | 2017-03-02 |
| (87) | Number | WO 2017/151979 |
| Date | 2017-09-08 |
| (30) | Number | Date | Country code |
| 201662302562 P | 2016-03-02 | US |
| (72) |
ALBONE, Earl, F., US
CHENG, Xin, US
CUSTAR, Daniel, W., US
FURUUCHI, Keiji, US
LI, Jing, US
MAJUMDER, Utpal, US
UENAKA, Toshimitsu, US
|
| (73) |
Eisai R&D Management Co., Ltd.,
6-10, Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūno-vaisto konjugatai eribulino pagrindu ir jų panaudojimo būdai |
| ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2026-02-18 | 10 | 231.00 EUR |
| 2027-03-02 |